0.99)與峰面積呈良好的線性關系。結論 建立了重組人IL-12注射液中泊洛沙姆188含量檢測的高效液相色譜法,并對建立的分析方法進行專屬性、準確度、精密度、檢測限、定量限、線性、范圍和耐用性的驗證,測定了3批重組人IL-12注射液中的泊洛沙姆188的量。;Objective To develop a HPLC method for potency determination of poloxamer 188 in recombinant human IL-12 injection. Methods A Waters Alliance 2695 system with a sepax poly RP-100 column was used for separation and subsequent detection by an evaporative light scattering detector(ELSD); 0.1%TFA-water and 0.1%TFA-acetonitrile were used as eluent A and B, and gradient elution conditions were as follows:0-5 min, 50%A→50%A; 5-6 min, 50%A→5%A; 6-12 min, 5%A→5%A; 12-13 min, 5%A→50%A; 13-20 min, 50%A→50%A. The flow rate was 1.0 mL/min; the column was maintained at 30℃. Results The RSD of retention time and peak area for poloxamer 188 were 0.19% and 1.7%, respectively (n=6); the recovery rates at low (50%), middle (100%) and high (150%) dose were 93.3%, 93.1% and 93.8%, and the average was 93.4%; the potency of poloxamer 188 between 1.5 μg and 9.0 μg was linearly related to peak area. Conclusions A HPLC for potency determination of poloxamer 188 in recombinant IL-12 injection was successfully developed and validated in specificity, accuracy, precion, limit of detection (LOD), limit of quantitation (LoQ), linearity, detection range and robustness. The developed method was finally applied to potency determination of poloxamer 188 in three recombinant IL-12 injections."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁 > 過刊瀏覽>2018年第41卷第9期 >2018,41(9):1644-1647. DOI:10.7501/j.issn.1674-6376.2018.09.014
上一篇 | 下一篇

蒸發(fā)光散射檢測法測定重組人IL-12注射液中泊洛沙姆188

Determination of Poloxamer 188 in Recombinant IL-12 Injection by HPLC-ELSD

發(fā)布日期:2018-09-07
您是第位訪問者
藥物評價研究 ® 2025 版權所有
技術支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號 互聯(lián)網藥品信息服務資格證書編號:(津)-非經營性-2015-0031